Now live: Pro — the full 13F research suite for serious investorsSee pricing →
FARALLON CAPITAL MANAGEMENT LLC

Q2 2024 · 13F-HR/A

FARALLON CAPITAL MANAGEMENT LLCholdings as filed

Filed 2025-11-14 · accession 0000908834-25-000348

$120.1M
Reported value
1
Positions
2024-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
023436108AMEDAMEDISYS INC$120.1M100.0%1,308,500CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.